John Woock - Sep 1, 2021 Form 4 Insider Report for Axonics, Inc. (AXNX)

Role
Chief Marketing Officer
Signature
/s/ Dan Dearen, as Attorney-in-Fact for John Woock, Ph.D
Stock symbol
AXNX
Transactions as of
Sep 1, 2021
Transactions value $
-$740,442
Form type
4
Date filed
9/3/2021, 06:52 PM
Previous filing
Aug 19, 2021
Next filing
Nov 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXNX Common Stock Options Exercise $8.15K +5K +16.7% $1.63* 34.9K Sep 1, 2021 Direct
transaction AXNX Common Stock Sale -$631K -8.44K -24.17% $74.73 26.5K Sep 1, 2021 Direct F1, F2
transaction AXNX Common Stock Sale -$118K -1.56K -5.88% $75.58 24.9K Sep 2, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXNX Stock Option (Right to Buy) Options Exercise $0 -3.44K -21.25% $0.00 12.8K Sep 1, 2021 Common Stock 3.44K $1.63 Direct F4
transaction AXNX Stock Option (Right to Buy) Options Exercise $0 -1.56K -12.21% $0.00 11.2K Sep 2, 2021 Common Stock 1.56K $1.63 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 15, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $73.82 to $75.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $75.00 to $76.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 The shares subject to the option vest over a period of four years. 7,800 of the shares subject to the option vested on March 30, 2018 and the remainder vest at a rate of 1/36th per month commencing on March 30, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.